Piovan E - Search Results

1

C and CX3C chemokines: cell sources and physiopathological implications.

Stievano L, Piovan E, Amadori A. Stievano L, et al. Among authors: piovan e. Crit Rev Immunol. 2004;24(3):205-28. doi: 10.1615/critrevimmunol.v24.i3.40. Crit Rev Immunol. 2004. PMID: 15482255 Review.

2

Alternatively spliced forms of Igalpha and Igbeta prevent B cell receptor expression on the cell surface.

Indraccolo S, Minuzzo S, Zamarchi R, Calderazzo F, Piovan E, Amadori A. Indraccolo S, et al. Among authors: piovan e. Eur J Immunol. 2002 Jun;32(6):1530-40. doi: 10.1002/1521-4141(200206)32:6<1530::AID-IMMU1530>3.0.CO;2-#. Eur J Immunol. 2002. PMID: 12115635

3

Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation.

Piovan E, Tosello V, Indraccolo S, Cabrelle A, Baesso I, Trentin L, Zamarchi R, Tamamura H, Fujii N, Semenzato G, Chieco-Bianchi L, Amadori A. Piovan E, et al. Blood. 2005 Feb 1;105(3):931-9. doi: 10.1182/blood-2004-03-0799. Epub 2004 Sep 28. Blood. 2005. PMID: 15454484

4

Differential regulation of hypoxia-induced CXCR4 triggering during B-cell development and lymphomagenesis.

Piovan E, Tosello V, Indraccolo S, Masiero M, Persano L, Esposito G, Zamarchi R, Ponzoni M, Chieco-Bianchi L, Dalla-Favera R, Amadori A. Piovan E, et al. Cancer Res. 2007 Sep 15;67(18):8605-14. doi: 10.1158/0008-5472.CAN-06-4722. Cancer Res. 2007. PMID: 17875700

5

Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.

Tosello V, Zamarchi R, Merlo A, Gorza M, Piovan E, Mandruzzato S, Bronte V, Wang X, Ferrone S, Amadori A, Zanovello P. Tosello V, et al. Among authors: piovan e. Eur J Immunol. 2009 Jan;39(1):56-66. doi: 10.1002/eji.200738098. Eur J Immunol. 2009. PMID: 19065646 Free PMC article.

6

Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination.

Tosello V, Bongiovanni D, Liu J, Pan Q, Yan KK, Saccomani V, Van Trimpont M, Pizzi M, Mazzoni M, Dei Tos AP, Amadori A, Zanovello P, Van Vlierberghe P, Yu J, Piovan E. Tosello V, et al. Among authors: piovan e. Leukemia. 2021 Apr;35(4):984-1000. doi: 10.1038/s41375-020-0999-2. Epub 2020 Jul 30. Leukemia. 2021. PMID: 32733009

7

Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia.

Bongiovanni D, Tosello V, Saccomani V, Dalla Santa S, Amadori A, Zanovello P, Piovan E. Bongiovanni D, et al. Among authors: piovan e. Oncogene. 2020 Oct;39(42):6544-6555. doi: 10.1038/s41388-020-01453-2. Epub 2020 Sep 11. Oncogene. 2020. PMID: 32917954

8

Chemotactic Cues for NOTCH1-Dependent Leukemia.

Piovan E, Tosello V, Amadori A, Zanovello P. Piovan E, et al. Front Immunol. 2018 Apr 3;9:633. doi: 10.3389/fimmu.2018.00633. eCollection 2018. Front Immunol. 2018. PMID: 29666622 Free PMC article. Review.

9

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.

Indraccolo S, Stievano L, Minuzzo S, Tosello V, Esposito G, Piovan E, Zamarchi R, Chieco-Bianchi L, Amadori A. Indraccolo S, et al. Among authors: piovan e. Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4216-21. doi: 10.1073/pnas.0506200103. Epub 2006 Mar 6. Proc Natl Acad Sci U S A. 2006. PMID: 16537511 Free PMC article.

10

In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab.

Macor P, Tripodo C, Zorzet S, Piovan E, Bossi F, Marzari R, Amadori A, Tedesco F. Macor P, et al. Among authors: piovan e. Cancer Res. 2007 Nov 1;67(21):10556-63. doi: 10.1158/0008-5472.CAN-07-1811. Cancer Res. 2007. PMID: 17975000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results